Sarcoidosis-Associated Pulmonary Hypertension.
Pulmonary hypertension
Sarcoidosis
Screening
Journal
Clinics in chest medicine
ISSN: 1557-8216
Titre abrégé: Clin Chest Med
Pays: United States
ID NLM: 7907612
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
medline:
21
1
2024
pubmed:
21
1
2024
entrez:
20
1
2024
Statut:
ppublish
Résumé
Pulmonary hypertension is a life-threatening complication of advanced sarcoidosis. Many mechanisms can cause an elevation of pulmonary pressure in sarcoidosis, leading to precapillary or postcapillary pulmonary hypertension. Sarcoidosis-associated pulmonary hypertension contributes to severe exertional dyspnea, reduced exercise capacity, and notably compromised the survival. Despite the critical functional and prognostic implications of pulmonary hypertension in sarcoidosis, there is a scarcity of specific guidelines on the management of these patients due to a lack of evidence. Hence, further research is required to identify subgroups of patients who may benefit from pulmonary arterial hypertension-targeted therapies and/or immunosuppressive therapies.
Identifiants
pubmed: 38245366
pii: S0272-5231(23)00076-X
doi: 10.1016/j.ccm.2023.08.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
185-197Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.